Plans to seek regulatory approval to commence a Phase III trial in the US and Canada VANCOUVER, BC, Jan. 8, 2026 /PRNewswire/ -- Sustained Therapeutics Inc. ("Sustained Therapeutics" or the "Company") ...
Forbes contributors publish independent expert analyses and insights. I track enterprise software application development & data management. Organizations buy, build, bolster and break down their IT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback